Acetaminophen and hydrocodone bitartrate and Neulasta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acetaminophen and hydrocodone bitartrate (acetaminophen; hydrocodone bitartrate) and Neulasta (pegfilgrastim). Common drug interactions include anaemia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Acetaminophen and hydrocodone bitartrate and Neulasta. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Acetaminophen and hydrocodone bitartrate?

Acetaminophen and hydrocodone bitartrate has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 6,101 Acetaminophen and hydrocodone bitartrate users. Check the latest studies of Acetaminophen and hydrocodone bitartrate.

What is Neulasta?

Neulasta has active ingredients of pegfilgrastim. It is often used in agranulocytosis. eHealthMe is studying from 92,286 Neulasta users. Check the latest studies of Neulasta.



On Jul, 20, 2026

22 people who take Acetaminophen and hydrocodone bitartrate and Neulasta together, and have interactions are studied.

Acetaminophen and hydrocodone bitartrate and Neulasta drug interactions.

What are the common drug interactions of Acetaminophen And Hydrocodone Bitartrate and Neulasta, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Breast cancer female
  3. Intervertebral disc protrusion (spinal disc protrusion)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Ovarian cyst (fluid filled sac of the ovary)
  6. Acne (skin problems that cause pimples)
  7. Alopecia (absence of hair from areas of the body)
  8. Conjunctivitis (pink eye)
  9. Erythema of eyelid (redness of the eyelid)
  10. Eyelid oedema (eyelids are swollen and contain excessive fluid)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Carcinoid tumour pulmonary (slow growing tumour)
  4. Catheter related infection
  5. Drug eruption (adverse drug reaction of the skin)
  6. Dyspnoea (difficult or laboured respiration)
  7. Haemoglobin decreased
  8. Hypersensitivity
  9. Infection
  10. Jugular vein thrombosis (clot in jugular vein)

What are the common drug interactions of Acetaminophen And Hydrocodone Bitartrate and Neulasta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Breast cancer female
  3. Intervertebral disc protrusion (spinal disc protrusion)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Ovarian cyst (fluid filled sac of the ovary)
  6. Acne (skin problems that cause pimples)
  7. Alopecia (absence of hair from areas of the body)
  8. Conjunctivitis (pink eye)
  9. Erythema of eyelid (redness of the eyelid)
  10. Eyelid oedema (eyelids are swollen and contain excessive fluid)

40-49:

n/a

50-59:

n/a

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Carcinoid tumour pulmonary (slow growing tumour)
  4. Catheter related infection
  5. Drug eruption (adverse drug reaction of the skin)
  6. Dyspnoea (difficult or laboured respiration)
  7. Haemoglobin decreased
  8. Hypersensitivity
  9. Infection
  10. Jugular vein thrombosis (clot in jugular vein)

What are the existing conditions these people have? *

  1. Vitiligo (pigment is lost from areas of the skin): 12 people, 54.55%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 9 people, 40.91%
  3. Wheezing (a high-pitched whistling sound made while you breath): 8 people, 36.36%
  4. Thrombosis (formation of a blood clot inside a blood vessel): 8 people, 36.36%
  5. High Blood Pressure: 8 people, 36.36%
  6. Gout (uric acid crystals building up in the body): 8 people, 36.36%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 36.36%
  8. Asbestosis (chronic lung disease caused by scarring of lung tissue, which stems from prolonged exposure to asbestos): 8 people, 36.36%
  9. Anaemia (lack of blood): 8 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take Acetaminophen and hydrocodone bitartrate and Neulasta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acetaminophen and hydrocodone bitartrate and Neulasta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acetaminophen and hydrocodone bitartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Neulasta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetaminophen and hydrocodone bitartrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neulasta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate and pegfilgrastim (the active ingredients of Acetaminophen and hydrocodone bitartrate and Neulasta, respectively), and Acetaminophen and hydrocodone bitartrate and Neulasta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: